The Ministry of Public Health, Siam Bioscience, SCG, and AstraZeneca collectively signed a Letter of Intent to manufacture and supply COVID-19 for Thailand and other nations in the region to ensure equitable and timely access to the COVID-19 vaccine.
In this regard, SCG Foundation has contributed 100 million Baht to domestic vaccine research and development. The first batch of vaccines is expected to be available in Thailand by mid-2021.
More information:
